Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Telik Inc.
Industry Drug Manufacturers - Other
Founded 1988
Headquarters Palo Alto, California, United States
Key people

Michael M. Wick M.D.
( Chairman, Chief Executive Officer, and President)
Wendy K. Wee
( Principal Financial & Accounting Officer )

Gail L. Brown M.D.
( Chief Medical Officer )
(Dec 31, 2012)
Number of employees
17 (Dec 31, 2012)

Telik, Inc. was set up in 1988 and was reverse merged into privately held MabVax in May 2014. The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.

In 2007, a class action was filed against Telik, Inc., alleging that they made false and misleading statements about the Company’s business and prospects during the Class Period.

Investment goal date:
Dividends reinvested
Telik Inc. TELK report
Period
Date
Adjusted Actuals EPS
GAAP EPS
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
EASTBOURNE CAPITAL MANAGEMENT LLC/CA
11.0000% (1532709)
TELK /
HOFFMAN ROBERT
0.0300% (4438)
ARNA / CBMX / HRTX / TELK /
MAFFUID PAUL W
0.1700% (24083)
TELK /
MAIER PAUL V
0.0300% (3762)
APRI / PURE / SQNM / TELK /
HANSON GREGORY P
0.2400% (33492)
TELK /
HANSEN JOHN DAVID
0.4700% (65759)
TELK /
WICK MICHAEL M
0.2400% (33551)
TELK /
CANTRALL EDWARD W
0.3600% (50000)
TELK /
BLACK BEAR OFFSHORE MASTER FUND LP
57.2100% (7971542)
TELK /
von Morze Herwig
0.1600% (22000)
TELK /
Cohen Kenneth M
0.0500% (7557)
ADMP / TELK /
Varvaro Thomas C
0.0200% (3086)
TELK /
Barry Richard J.
85.0300% (11847125)
TELK /
Barry Richard
1.7500% (243800)
SRPT / TELK /
Antonopoulos Jim J.
0.1500% (21258)
TELK /
Livingston Philip O.
9.3800% (1307396)
TELK /
Ravetch Jeffrey V.
0.0200% (3086)
TELK /
Scholz Wolfgang W.
0.8100% (113288)
TELK /